Bishop's Stortford, United Kingdom

Mark R Shipton


Average Co-Inventor Count = 6.0

ph-index = 3

Forward Citations = 12(Granted Patents)


Location History:

  • Bishop's Stortford, GB (1997 - 1999)
  • Hertfordshire, GB (1999)

Company Filing History:


Years Active: 1997-1999

Loading Chart...
6 patents (USPTO):Explore Patents

Title: Mark R Shipton: Innovator in Pharmaceutical Chemistry

Introduction

Mark R Shipton is a notable inventor based in Bishop's Stortford, GB. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that act as 5-HT1-like agonists. With a total of six patents to his name, his work has implications for various therapeutic applications.

Latest Patents

Among his latest patents, Shipton has developed an enantiomer of a carbazole derivative that functions as a 5-HT1-like agonist. This compound, characterized by a specific formula, includes variations where R.sup.4 is either methyl or ethyl. The patent details processes for preparing these compounds, as well as pharmaceutical compositions that incorporate them. The compounds of formula (+) are particularly noted for their agonistic properties.

Career Highlights

Mark R Shipton is associated with Smithkline Beecham Corporation, where he has been instrumental in advancing research and development in pharmaceutical sciences. His innovative approaches have led to the creation of valuable compounds that contribute to the understanding and treatment of various medical conditions.

Collaborations

Throughout his career, Shipton has collaborated with esteemed colleagues such as Gary Thomas Borrett and John Kitteringham. These partnerships have fostered a collaborative environment that enhances the research output and innovation within the field.

Conclusion

Mark R Shipton's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as a significant inventor in the industry. His work continues to influence the development of new therapeutic agents.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…